HKD 2.84
(1.43%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 46.06 Billion CNY | 6.78% |
2022 | 43.13 Billion CNY | 12.25% |
2021 | 38.43 Billion CNY | 94.24% |
2020 | 19.78 Billion CNY | 5.0% |
2019 | 18.84 Billion CNY | -8.46% |
2018 | 20.58 Billion CNY | 10.32% |
2017 | 18.65 Billion CNY | 52.73% |
2016 | 12.21 Billion CNY | 22.25% |
2015 | 9.99 Billion CNY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 12.6 Billion CNY | -0.11% |
2024 Q2 | 12.6 Billion CNY | 0.0% |
2023 Q1 | 10.41 Billion CNY | 1.07% |
2023 FY | 46.06 Billion CNY | 6.78% |
2023 Q4 | 12.61 Billion CNY | 0.0% |
2023 Q3 | 12.61 Billion CNY | 21.15% |
2023 Q2 | 10.41 Billion CNY | 0.0% |
2022 Q1 | 11.26 Billion CNY | 8.47% |
2022 Q4 | 10.3 Billion CNY | 0.0% |
2022 FY | 43.13 Billion CNY | 12.25% |
2022 Q3 | 10.3 Billion CNY | -8.52% |
2022 Q2 | 11.26 Billion CNY | 0.0% |
2021 Q2 | 9.29 Billion CNY | 0.0% |
2021 FY | 38.43 Billion CNY | 94.24% |
2021 Q1 | 9.29 Billion CNY | 59.63% |
2021 Q3 | 10.38 Billion CNY | 11.67% |
2021 Q4 | 10.38 Billion CNY | 0.0% |
2020 FY | 19.78 Billion CNY | 5.0% |
2020 Q4 | 5.82 Billion CNY | 0.0% |
2020 Q3 | 5.82 Billion CNY | 43.26% |
2020 Q2 | 4.06 Billion CNY | 0.0% |
2020 Q1 | 4.06 Billion CNY | -6.71% |
2019 Q2 | 5.06 Billion CNY | 0.0% |
2019 FY | 18.84 Billion CNY | -8.46% |
2019 Q1 | 5.06 Billion CNY | 2.75% |
2019 Q4 | 4.35 Billion CNY | 0.0% |
2019 Q3 | 4.35 Billion CNY | -13.88% |
2018 Q1 | 5.04 Billion CNY | 22.48% |
2018 Q2 | 5.04 Billion CNY | 0.0% |
2018 Q3 | 5.56 Billion CNY | 10.17% |
2018 Q4 | 4.92 Billion CNY | -11.41% |
2018 FY | 20.58 Billion CNY | 10.32% |
2017 Q4 | 4.12 Billion CNY | 0.0% |
2017 FY | 18.65 Billion CNY | 52.73% |
2016 FY | 12.21 Billion CNY | 22.25% |
2015 FY | 9.99 Billion CNY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 773.65 Million HKD | -5854.328% |
Lee & Man Chemical Company Limited | 4.05 Billion HKD | -1037.266% |